EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS

Daniel Christoph Amberger iD, Zuzana Fischer, Diana Deen, Anika Hirn-Lopez, Caroline Plett, Alexander Rabe, Christoph Schwepcke, Selda Ugur, Lara Kristina Klauer iD, Christian Ansprenger, Anja Liepert, Markus Freudenreich und 2 weitere

Cancers · 06.03.2026 · 18 (5) · 847

DOI: 10.3390/cancers18050847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 06.03.2026. Verfasst von Daniel Christoph Amberger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital of Munich and the University Hospital of Augsburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Acute myeloid leukemia (AML) is characterized by impaired anti-leukemic immune responses, and the ex vivo or in vivo generation of dendritic cells (DCs), including leukemic dendritic cells (DCleu), represents a promising strategy to stimulate immune cells and improve anti-leukemic activity.

Methods

This study examined the generation, phenotype and functional relevance of DCs and DCleu produced ex vivo from blast-containing PBMNCs and whole blood (WB) in AML. Using both standard DC/DCleu-generating protocols and available Kits.

Results

We show that DC/DCleu can be reliably generated with both methods. Generated DC/DCleu effectively activated T cells during mixed lymphocyte cultures (MLCs), resulting in enhanced anti-leukemic cytotoxicity. Improved blast lysis correlated with specific immunological features, including higher frequencies of generated DCleu and mature DC subsets, as well as a certain cytokine pattern after DC/DCleu cultures or MLC. In addition, the frequencies of proliferating T cells after MLC strongly correlated with the degree of achieved blast lysis, underscoring the importance of efficient DC/DCleu-mediated T cell stimulation. Both the frequencies of generated DC/DCleu and the resulting blast lytic activity were linked to overall survival (OS) in AML patients. Individuals who failed to demonstrate improved blast lysis exhibited significantly reduced OS, suggesting inadequate immune responsiveness of patients in vivo.

Conclusions

These findings identify phenotypic and functional immune parameters as predictors of clinical outcome and highlight the prognostic relevance of ex vivo immune profiling. This approach may help to optimize and personalize future immunotherapeutic strategies in AML.

Schlagwörter

Stichwörter der Autor:innen

AMLDC/DCleu-generating protocolsanti-leukaemic activityleukaemia-derived dendritic cells

Autor:innen und Institutionen

  • Department of Medicine III, University Hospital of Ludwig-Maximilian-University Munich, 81377 Munich, Germany.
  • First Department of Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.
  • Bavarian Cancer Research Center (BZKF), 80539 Munich, Germany.
  • Department of Haematology and Oncology, University Hospital of Augsburg, 86156 Augsburg, Germany.

ORCID-Profile: Daniel Christoph Amberger, Lara Kristina Klauer

Förderung

  • University Hospital of Munich and the University Hospital of Augsburg

Zitieren

APA

Amberger, D. C., Fischer, Z., Deen, D., Hirn-Lopez, A., Plett, C., Rabe, A., Schwepcke, C., Ugur, S., Klauer, L. K., Ansprenger, C., Liepert, A., Freudenreich, M., Schmid, C., & Schmetzer, H. M. (2026). Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS. Cancers, 18(5), 847. https://doi.org/10.3390/cancers18050847

Vancouver

Amberger DC, Fischer Z, Deen D, Hirn-Lopez A, Plett C, Rabe A, et al. Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS. Cancers. 2026;18(5):847. doi:10.3390/cancers18050847

BibTeX
@article{Amberger2026,
  author = {Amberger, Daniel Christoph and Fischer, Zuzana and Deen, Diana and Hirn-Lopez, Anika and Plett, Caroline and Rabe, Alexander and Schwepcke, Christoph and Ugur, Selda and Klauer, Lara Kristina and Ansprenger, Christian and Liepert, Anja and Freudenreich, Markus and Schmid, Christoph and Schmetzer, Helga Maria},
  title = {Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {847},
  doi = {10.3390/cancers18050847}
}
Kostenlos starten →